Does intravenous tranexamic acid reduce bleeding during mastoidectomy?

Samaneh Ziaei1, Saeid Sadeghi Joni2, Reza Shahriar3

  • 1DDS, MS. Assistant Professor, Dept. of Dral and Maxillofacial Medicine, Faculty of Dentistry, Sharekord Branch Shahrekord, Iran.

Insights

Tranexamic acid significantly reduces bleeding during mastoidectomy, a crucial head and neck surgery. This improves surgical visualization and patient outcomes by minimizing blood loss.

Area of Science:

  • Otolaryngology
  • Surgical Hemostasis
  • Anesthesiology

Background:

  • Mastoidectomy is a vital head and neck surgical procedure often necessitated by otitis media complications.
  • Microscopic mastoidectomy demands a clear surgical field, which is frequently compromised by intraoperative bleeding.
  • Effective bleeding control is paramount for successful microscopic surgical outcomes.

Purpose of the Study:

  • To investigate the efficacy of tranexamic acid in mitigating blood loss during mastoidectomy.
  • To assess the impact of tranexamic acid on surgical visualization and patient hemodynamic parameters.

Main Methods:

  • A randomized clinical trial involving 69 patients undergoing mastoidectomy.
  • Patients were allocated to receive either tranexamic acid (10 mg/kg) or a normal saline placebo.
  • Data collected included bleeding volume, surgery duration, heart rate, and blood pressure.

Main Results:

  • Tranexamic acid administration was associated with a statistically significant reduction in bleeding during mastoidectomy (P<0.001).
  • A significant decrease in blood pressure was also observed in the tranexamic acid group.
  • No significant difference in surgery duration was noted between groups.

Conclusions:

  • Tranexamic acid is an effective agent for reducing intraoperative bleeding in mastoidectomy.
  • The use of tranexamic acid can enhance surgical field visualization for otolaryngologists.
  • Administering tranexamic acid is recommended for microscopic surgeries to improve outcomes.